Cognito Therapeutics, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.cognitotx.com
Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
- Conditions
- Alzheimer DiseaseMild Cognitive ImpairmentADDementia ModerateDementia AlzheimersDementia of Alzheimer TypeCognitive ImpairmentDementia, Mild
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Cognito Therapeutics, Inc.
- Target Recruit Count
- 402
- Registration Number
- NCT06245031
- Locations
- 🇺🇸
Barrow Neurological Institute, Phoenix, Arizona, United States
🇺🇸CCT Research - Foothills Research Center, Phoenix, Arizona, United States
🇺🇸Banner Sun Health Research Institute, Sun City, Arizona, United States
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011)
- Conditions
- Alzheimer Disease 2Alzheimer Disease 17Alzheimer's Dementia Late OnsetAlzheimer Disease 1Alzheimer Disease 6Alzheimer Disease 10Alzheimer Disease 13Dementia of Alzheimer TypeDementia ModerateDementia Senile
- First Posted Date
- 2022-12-05
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Cognito Therapeutics, Inc.
- Target Recruit Count
- 670
- Registration Number
- NCT05637801
- Locations
- 🇺🇸
CCT Research - Gilbert Neurology Partners, Gilbert, Arizona, United States
🇺🇸Barrow Neurological Institute, Phoenix, Arizona, United States
🇺🇸CCT Research - Foothills Research Center, Phoenix, Arizona, United States
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
- Conditions
- Alzheimer Disease, Early OnsetAlzheimer DiseaseMemory ImpairmentAlzheimer Disease, Late OnsetCognitive ImpairmentDementia, MildMild Cognitive ImpairmentDementia, Alzheimer TypeAlzheimer DementiaMemory Disorders
- First Posted Date
- 2018-09-07
- Last Posted Date
- 2021-08-24
- Lead Sponsor
- Cognito Therapeutics, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT03661034
- Locations
- 🇺🇸
Boston Center for Memory, Newton, Massachusetts, United States
Multi-Center Study of Sensory Stimulation to Improve Brain Function
- Conditions
- Alzheimer DiseaseMild Cognitive ImpairmentDementia AlzheimersDementiaCognitive ImpairmentDementia, MildCognitive Impairment, MildCognitive DeclineDementia, Alzheimer TypeDementia of Alzheimer Type
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2021-08-24
- Lead Sponsor
- Cognito Therapeutics, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT03556280
- Locations
- 🇺🇸
Brain Matters Research, Stuart, Florida, United States
🇺🇸ActivMed Practices & Research, Inc, Methuen, Massachusetts, United States
🇺🇸Boston Center for Memory, Newton, Massachusetts, United States